Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Carbon nanotube nanocomposite scaffolds: advances in fabrication and applications for tissue regeneration and cancer therapy. | Front Bioeng Biotechnol | 2023 | 38179128 | PubTator, text mining | PubMed |
| LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers. | Front Mol Biosci | 2023 | 38152110 | PubTator, text mining | PubMed |
| Spatial Proteomics toward Subcellular Resolution by Coupling Deep Ultraviolet Laser Ablation with Nanodroplet Sample Preparation. | ACS Meas Sci Au | 2023 | 38145026 | PubTator, text mining | PubMed |
| Phenotype-Genotype Correlations in Three Different Cases of Adult-Onset Genetic Focal Segmental Glomerulosclerosis. | Int J Mol Sci | 2023 | 38139322 | PubTator, text mining | PubMed |
| NUP85 as a Neurodevelopmental Gene: From Podocyte to Neuron. | Genes (Basel) | 2023 | 38136965 | PubTator, text mining | PubMed |
| LLGL2 Inhibits Ovarian Cancer Metastasis by Regulating Cytoskeleton Remodeling via ACTN1. | Cancers (Basel) | 2023 | 38136424 | PubTator, text mining | PubMed |
| Proteomic analysis of small extracellular vesicles unique to cervical cancer. | Transl Cancer Res | 2023 | 38130315 | PubTator, text mining | PubMed |
| Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment. | Front Endocrinol (Lausanne) | 2023 | 38116315 | PubTator, text mining | PubMed |
| A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action. | Food Sci Nutr | 2023 | 38107139 | PubTator, text mining | PubMed |
| Diagnosis of Glomerular Disease With Podocyte Infolding, Microspherical, and Microtubular Glomerular Basement Membrane Inclusions. | Kidney Int Rep | 2023 | 38106589 | PubTator, text mining | PubMed |
| Podocyte Infolding Glomerulopathy: A Special Morphology of Podocyte Injury Caused by Heterogeneous Diseases. | Kidney Int Rep | 2023 | 38106587 | PubTator, text mining | PubMed |
| Identification of novel immune cell signature in gastroesophageal reflux disease: altered mucosal mast cells and dendritic cell profile. | Front Immunol | 2023 | 38098488 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer. | Sci Rep | 2023 | 38097783 | PubTator, text mining | PubMed |
| Prostate cancer-derived small extracellular vesicle proteins: the hope in diagnosis, prognosis, and therapeutics. | J Nanobiotechnology | 2023 | 38093355 | PubTator, text mining | PubMed |
| Structural basis for subversion of host cell actin cytoskeleton during Salmonella infection. | Sci Adv | 2023 | 38064550 | PubTator, text mining | PubMed |
| ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3β and integrin β1-mediated phosphorylation of FAK. | J Exp Clin Cancer Res | 2023 | 38057867 | PubTator, text mining | PubMed |
| Evolving insights in blood-based liquid biopsies for prostate cancer interrogation. | Oncoscience | 2023 | 38033786 | PubTator, text mining | PubMed |
| Sphingosine kinase 1/S1P receptor signaling axis is essential for cellular uptake of Neisseria meningitidis in brain endothelial cells. | PLoS Pathog | 2023 | 38033162 | PubTator, text mining | PubMed |
| FOXD1 expression-based prognostic model for uveal melanoma. | Heliyon | 2023 | 38027647 | PubTator, text mining | PubMed |
| Bioinspired extracellular vesicle-coated silica nanoparticles as selective delivery systems. | Mater Today Bio | 2023 | 38024844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=8